BloodHumansMultiple MyelomaImmunotherapyAdoptiveMale
Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR data.
Rahul Banerjee, Christy Khouderchah, Othman S Akhtar, Emily C Liang, Jordan Gauthier, Madhav V Dhodapkar, Andrew J Portuguese
Published: 202610.1182/blood.2025031426
Abstract
ABSTRACT: Recent analyses have suggested a possible negative impact of prior autologous stem cell transplantation on outcomes with idecabtagene vicleucel (ide-cel) chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma. Our…
Preview only. Read the full abstract at the source